Streetbeat News

Acquisitions Mergers

LLY

PRQR

ProQR has successfully raised $75 million through a public offering and a private placement with strategic partner Eli Lilly. This funding is expected to support ProQR's ongoing research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 6:09 am

SYNA

Synaptics is expanding its operations in Taiwan to capitalize on the rapid growth of the $24 billion AI IoT industry.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 5:39 am

JBLU

SAVE

ULCC

Spirit Airlines' stock surged over 16% in after-hours trading following reports of renewed merger interest from Frontier Group Holdings. The potential merger discussions are in early stages and may coincide with Spirit's bankruptcy restructuring. Spirit has been under financial strain, especially after a failed merger with JetBlue.

Portfolio Pulse from Benzinga Neuro

October 23, 2024 | 3:11 am

BERY

GLT

Berry Global has set a record date for the spin-off of its HHNF Business, which will merge with Glatfelter and result in a new entity, Magnera Corporation. The transaction is expected to complete on November 4, 2024, pending closing conditions.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 10:00 pm

UP

Wheels Up Experience has entered into an agreement to acquire Grandview Aviation's entire fleet of 17 Phenom 300 and Phenom 300E aircraft for $105 million.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 8:42 pm

FBMS

The First Bancshares, Inc. (NYSE:FBMS) has received shareholder approval for its merger with Renasant Corporation. The merger is still subject to regulatory approvals and customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 8:35 pm

PETQ

PetIQ shareholders have approved a merger agreement for Bansk Group to acquire all outstanding shares of PetIQ's common stock for $31.00 per share, in a transaction valued at approximately $1.5 billion.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 8:19 pm

OCUP

Ocuphire Pharma has announced the acquisition of Opus Genetics, creating a leading company in gene therapy for retinal diseases. The merger will result in a name change to Opus Genetics, Inc., with a new Nasdaq ticker 'IRD'. The company is seeking a strategic partner for APX3330 development and has extended its cash runway into 2026.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 8:17 pm

OCUP

Ocuphire Pharma has acquired Opus Genetics, issuing 5.2 million common shares and 14.1 thousand convertible preferred shares to Opus Genetics' stockholders. Ocuphire will own 58% of the combined company, while Opus Genetics' stockholders will own 42%.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 8:16 pm

ALSN

Allison Transmission's venture capital arm, Allison Ventures, has invested in Agtonomy, a company specializing in AI-enabled automation software for agriculture and land maintenance. This strategic investment aims to enhance Agtonomy's capabilities in improving commercial productivity and operational efficiency.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 8:13 pm